A major international effort is renaming polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS), reflecting a broader scientific understanding of the condition as a multisystem disorder affecting metabolic, hormonal, reproductive, and mental health. The change, following a global consensus process led by endocrinology experts and patient advocacy organizations including the Endocrine Society, aims to address decades of medical confusion about the condition.
For years, the name “polycystic ovary syndrome” contributed to widespread misunderstanding. Many patients were told they did not have PCOS if cysts were not visible on ultrasound, despite ovarian cysts not being required for diagnosis. Symptoms vary widely and can include irregular menstrual cycles, elevated androgen levels, acne, hair growth or loss, infertility, and metabolic complications. This confusion has contributed to delayed diagnosis and fragmented care, with some patients remaining undiagnosed or misdiagnosed for years, cycling through providers before receiving a clear explanation for their symptoms.
The new term PMOS emphasizes the condition’s metabolic dimension, including links to insulin resistance, type 2 diabetes risk, and cardiovascular health. PMOS affects roughly 1 in 8 women globally, making it one of the most common endocrine disorders in reproductive-aged women. Patient advocates involved in the renaming process describe the shift as “a long-overdue correction” that attempts to align medical language with lived experience and ensure symptoms long dismissed or misinterpreted are recognized sooner.
However, experts caution that a name change alone will not resolve long-standing gaps in research funding, clinical training, or access to care. The impact of the reclassification will depend heavily on whether medical practice follows the science. Diagnostic criteria remain unchanged for now.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.salon.com/2026/05/16/pcos-is-now-pmos-millions-of-women-might-now-get-better-diagnosis-treatment/